|
Volumn 62, Issue 11, 2010, Pages 1542-1551
|
Abatacept improves health-related quality of life, pain, sleep quality, and daily participation in subjects with juvenile idiopathic arthritis.
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ABATACEPT;
ANTIBODY CONJUGATE;
ADOLESCENT;
ARTICLE;
CHILD;
CLINICAL TRIAL;
COMPARATIVE STUDY;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
HEALTH STATUS;
HUMAN;
JUVENILE RHEUMATOID ARTHRITIS;
MALE;
PAIN;
PATHOPHYSIOLOGY;
PHASE 3 CLINICAL TRIAL;
PHYSIOLOGY;
PSYCHOLOGICAL ASPECT;
QUALITY OF LIFE;
QUESTIONNAIRE;
RANDOMIZED CONTROLLED TRIAL;
SLEEP STAGE;
ADOLESCENT;
ARTHRITIS, JUVENILE RHEUMATOID;
CHILD;
DOUBLE-BLIND METHOD;
FEMALE;
HEALTH STATUS;
HUMANS;
IMMUNOCONJUGATES;
MALE;
PAIN;
QUALITY OF LIFE;
QUESTIONNAIRES;
SLEEP STAGES;
|
EID: 79952063531
PISSN: None
EISSN: 21514658
Source Type: Journal
DOI: 10.1002/acr.20283 Document Type: Article |
Times cited : (73)
|
References (0)
|